The Tianqiao & Chrissy Chen Institute’s OMNE Framework for Long-term AI Memory Claims Top Spot on GAIA Leaderboard
REDWOOD CITY, Calif., Oct. 28, 2024 /PRNewswire/ -- Drawing on their deep knowledge of the brain and memory, the Tianqiao...
Day: October 29, 2024
Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI
Investments will support new product offerings, US expansion, and development of pathology foundation models. BERLIN and NEW YORK, Oct. 29,...
AiRISTA Awarded Asset Tracking & Management Solutions agreement with Premier, Inc.
TIMONIUM, Md., Oct. 29, 2024 /PRNewswire/ -- AiRISTA, a global leader in real time location services (RTLS), has been awarded...
Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 6, 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / October 29, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release...
BioNxt Announces National Level Patent Filings for Sublingual Anticancer Drugs for the Treatment of Autoimmune Neurodegenerative Diseases
VANCOUVER, BC / ACCESSWIRE / October 29, 2024 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT) is pleased...
IRLAB Reports Continued Progress Ahead of the Mesdopetam Phase III Program
GOTHENBURG, SWEDEN / ACCESSWIRE / October 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company...